Boston Partners Taro Pharmaceutical Industries LTD Transaction History

Boston Partners

  • $80.6 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2019

May 03, 2019
SELL
$85.97 - $108.09 $1.26 Million - $1.58 Million
-14,643 Closed
0 $0
Q4 2018

Feb 07, 2019
SELL
$78.25 - $107.92 $646,188 - $891,203
-8,258 Reduced 36.06%
14,643 $1.24 Million
Q3 2018

Nov 14, 2018
SELL
$97.82 - $116.09 $62,604 - $74,297
-640 Reduced 2.72%
22,901 $2.25 Million
Q2 2018

Aug 03, 2018
BUY
$97.62 - $120.59 $2.3 Million - $2.84 Million
23,541 New
23,541 $2.72 Million

Others Institutions Holding TARO

# of Institutions
9
Shares Held
17K
Call Options Held
0
Put Options Held
0
View Full List

About TARO PHARMACEUTICAL INDUSTRIES LTD

TARO Quotes by TradingView
  • Ticker TARO
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 37,584,600
  • Description
  • Taro Pharmaceutical Industries Ltd., a science-based pharmaceutical company, develops, manufactures, and markets prescription and over-the-counter pharmaceutical products in the United States, Canada, Israel, and internationally. The company also develops and manufactures active pharmaceutical ingredients primarily for use in its finished dosage...
More about TARO
Track This Portfolio

Track Boston Partners Portfolio

Follow Boston Partners and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Boston Partners, based on Form 13F filings with the SEC.

News

Stay updated on Boston Partners with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email